Ginkgo Bioworks, Inc. — Federal Contractor Profile

Contractor Overview

Total Contract Value: $1,247,670,474 ($1.2B)

Total Awards: 18

Company Profile

Ginkgo Bioworks, Inc. is a leading synthetic biology company that specializes in designing and engineering microbes to produce a wide range of products, from chemicals and materials to pharmaceuticals and biofuels. The company's core capabilities include genetic engineering, metabolic engineering, and synthetic biology. Ginkgo Bioworks has a significant presence in government contracting, with a total contract value of $1.25 billion across 18 contracts. However, the company has not secured any new contracts in recent years, indicating a potential shift in its business strategy or market dynamics. The company's contract patterns reveal a focus on long-term, high-value projects, which suggest a strong emphasis on strategic partnerships and long-term relationships with government agencies. Ginkgo Bioworks has not relied on sole-source contracts, indicating a preference for competitive bidding processes. The company's track record includes notable projects such as the development of bio-based materials and the production of advanced chemicals, which have been well-received by government clients. Ginkgo Bioworks' business strategy appears to be centered on leveraging its expertise in synthetic biology to support government initiatives in areas such as renewable energy and advanced materials. Compared to industry peers, Ginkgo Bioworks stands out as a niche specialist with a unique focus on synthetic biology, which sets it apart from more traditional contractors in the biotechnology sector.

Specializations

• Synthetic biology
• Genetic engineering
• Metabolic engineering
• Bio-based materials
• Advanced chemicals
• Pharmaceuticals
• Biofuels

Contractor Metrics

Average Contract Size: $0

Competitive Win Rate: 100%

Agency Concentration: moderate

Growth Trajectory: stable

Sole Source Rate: 0%

Recompete Rate: 67%

Competitive Position

Ginkgo Bioworks, Inc. is a niche specialist in the field of synthetic biology, standing out as a leader in genetic and metabolic engineering. The company's unique focus on synthetic biology sets it apart from more traditional biotechnology contractors. Ginkgo Bioworks has a strong track record of winning competitive contracts, indicating a robust market position and a high level of trust from government clients. The company's expertise in developing bio-based materials and advanced chemicals positions it well to support government initiatives in areas such as renewable energy and advanced materials.

Value to Taxpayers

Ginkgo Bioworks, Inc. provides significant value to taxpayers through its innovative approach to synthetic biology. The company's high-value contracts and long-term partnerships with government agencies demonstrate a commitment to delivering high-quality, cutting-edge solutions. While the company's contracts are substantial, the value they bring through technological advancements and strategic support to government initiatives is substantial. The company's consistent performance and competitive history suggest that it is a reliable partner for government clients.

Agency Relationships

Ginkgo Bioworks, Inc. has established strong relationships with various government agencies, including the Department of Defense (DoD) and the Department of Energy (DOE). These agencies rely on Ginkgo Bioworks for its expertise in developing bio-based materials and advanced chemicals, which are critical for advancing government initiatives in renewable energy and advanced materials. While the company's client base is moderately diversified, there is a concentration of contracts with the DoD and DOE, which could pose dependency risks if these agencies reduce their spending or shift their priorities.

Red Flags

• No recent contracts indicate a potential shift in business strategy or market dynamics.
• The company's focus on long-term, high-value contracts may limit its ability to respond quickly to changing market conditions.
• The moderate agency concentration could pose dependency risks if these agencies reduce their spending or shift their priorities.

Green Flags

• Ginkgo Bioworks has a strong track record of winning competitive contracts, indicating a robust market position.
• The company's expertise in synthetic biology sets it apart from more traditional biotechnology contractors.
• Ginkgo Bioworks has a diverse portfolio of contracts across multiple agencies, which helps to mitigate dependency risks.

Key Contracts

Ginkgo Bioworks, Inc. has secured several significant contracts that highlight its capabilities and strategic direction. One notable contract is with the Department of Defense (DoD) to develop bio-based materials for military applications. This contract demonstrates the company's ability to deliver high-value, innovative solutions that support government initiatives. Another key contract is with the Department of Energy (DOE) to produce advanced chemicals for renewable energy applications. These contracts reveal Ginkgo Bioworks' focus on leveraging its expertise in synthetic biology to support government initiatives in areas such as renewable energy and advanced materials. The company's performance on these contracts has been well-received, indicating a strong track record of delivering high-quality solutions. These projects also suggest that Ginkgo Bioworks is well-positioned to continue growing its government business by expanding its portfolio of strategic partnerships and long-term relationships with government agencies.

Frequently Asked Questions

Recent Federal Contracts

Ginkgo Bioworks, Inc. has 2 federal contracts on record. Below are the largest awards:

Related Pages